Literature DB >> 26626298

Health Care Costs and Utilization in Patients Receiving Prescriptions for Long-acting Opioids for Acute Postsurgical Pain.

Laura S Gold1, Scott A Strassels, Ryan N Hansen.   

Abstract

OBJECTIVES: Severe pain after joint replacement surgeries is common and is usually managed by opioid analgesics. We described joint replacement surgery patients who received prescriptions for long-acting opioids (LAOs) and compared their health care utilization and costs with postsurgical patients who did not receive LAO prescriptions.
MATERIALS AND METHODS: Patients undergoing hip, knee, or shoulder replacement surgery between January 1, 2008 and December 31, 2011were included in the study and were classified by their exposure to LAOs. We estimated multivariate models to compare the groups' health care utilization and costs in the first 7 days and in the 1, 3, 6, and 12 months after surgery.
RESULTS: Of 118,816 patients who met our inclusion criteria, 15,094 (13%) received LAO prescriptions in 30 days following surgery. LAO recipients were slightly younger and more likely than nonrecipients to have taken antibiotics, antidepressants, benzodiazepines, antihypertensives, sedatives, muscle relaxants, and short-acting opioids in the 60 days before surgery. LAO recipients were more likely to have had a hospitalization and an emergency department visit in the subsequent 1 week and in the next 1, 3, 6, and 12 months. Patients receiving LAO prescriptions incurred greater costs in the 1 week and in the 1, 3, 6, and 12 months following their surgeries compared with patients who did not receive LAO prescriptions. DISCUSSION: We found associations between patients who received prescriptions for LAOs and increased costs and utilization. Future studies should elucidate causal relationships between LAOs and increased resource use. Providers should consider alternative pain management strategies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26626298     DOI: 10.1097/AJP.0000000000000322

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

1.  Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck.

Authors:  Brent A Metfessel; Michelle D Mentel; Amy Phanel; Mary Ann Dimartino; Mureen Allen; Samuel Ho
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

2.  Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014.

Authors:  Catherine L Chen; Molly Moore Jeffery; Erin E Krebs; Cornelius A Thiels; Mark A Schumacher; Adam J Schwartz; Robert Thombley; Emily Finlayson; Rosa Rodriguez-Monguio; Derek Ward; R Adams Dudley
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-01-07

3.  Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients.

Authors:  Chad M Brummett; Jackie Evans-Shields; Christina England; Amanda M Kong; Carolyn R Lew; Caroline Henriques; Nicole M Zimmerman; Eric C Sun
Journal:  J Manag Care Spec Pharm       Date:  2021-02-24

4.  Reduced length of stay and hospitalization costs among inpatient hysterectomy patients with postoperative pain management including IV versus oral acetaminophen.

Authors:  Ryan N Hansen; An T Pham; Elaine A Boing; Belinda Lovelace; George J Wan; Richard D Urman
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

5.  Access Is Necessary but Not Sufficient: Factors Influencing Delay and Avoidance of Health Care Services.

Authors:  Kyle T Smith; Denise Monti; Nageen Mir; Ellen Peters; Renuka Tipirneni; Mary C Politi
Journal:  MDM Policy Pract       Date:  2018-03-26

6.  Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014.

Authors:  Catherine L Chen; Molly Moore Jeffery; Erin E Krebs; Cornelius A Thiels; Mark A Schumacher; Adam J Schwartz; Robert Thombley; Emily Finlayson; Rosa Rodriguez-Monguio; Derek Ward; R Adams Dudley
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.